Alzheimer's disease (AD) is the most common form of dementia affecting specifically older
population. AD is an irreversible neurodegenerative CNS disorder associated with complex …

Alzheimer's disease (AD) is a progressive neurodegenerative disorder of the central
nervous system (CNS) which is the most common cause of dementia in the elderly. It is …

Coumarins and their derivatives are receiving increasing attention due to numerous
biochemical and pharmacological applications. In this study, a series of novel coumarin–1 …

Three new alkaloids, bersavine (3), muraricine (4), and berbostrejdine (8), together with
seven known isoquinoline alkaloids (1–2, 5–7, 9, and 10) were isolated from an alkaloidal …

The pharmacology, dosage, adverse effects, efficacy, and economics of galantamine
hydrobromide are discussed. Galantamine hydrobromide is a tertiary alkaloid that has been …

The only prescribed drugs for treatment of Alzheimer's disease (AD) are
acetylcholinesterase inhibitors (eg, donepezil, rivastigmine, galantamine, and tacrine) and …

Current approaches to the treatment of cognitive and behavioral symptoms of Alzheimer
disease emphasize the use of cholinesterase inhibitors. The kinetic effects of the …

Butyrylcholinesterase (BChE) is a nonspecific cholinesterase enzyme that hydrolyzes
choline-based esters. BChE plays a critical role in maintaining normal cholinergic function …

Alzheimer's disease is a multifactorial syndrome, for which effective cures are urgently
needed. Seeking for enhanced therapeutic efficacy, multitarget drugs have been …

Alzheimer's disease is a most prevalent form of dementia all around the globe and currently
poses a significant challenge to the healthcare system. Currently available drugs only slow …